(9-075) Impact of a Once Weekly Glucagon-like Peptide-1 Receptor Agonist on Insulin Dose and Injection Burden in a Federally Qualified Health Center

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Ambulatory Care

Co-Author(s): Jacob Northup

Primary Author(s)

Caroline B. Adrian, PharmD
PGY-1 Community Pharmacy Resident
Sun Life Health, Arizona